Juha Rantala

Biochemistry, Genetics and Molecular Biology · Life Sciences

25h-index2.8kcitations89works0.82yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA Interference and Gene Delivery(12), Advanced biosensing and bioanalysis techniques(9), Microtubule and mitosis dynamics(9), Cancer Cells and Metastasis(8), Cancer Genomics and Diagnostics(7)

Publications88 total

FANCD2 restrains fork progression and prevents fragility at early origins upon re-replication
Nature Communications·2026Open Access
Full analysis on imaging data (siRNA-based High content screening)
Zenodo (CERN European Organization for Nuclear Research)·2025Open Access
Full analysis on imaging data (siRNA-based High content screening)
Zenodo (CERN European Organization for Nuclear Research)·2025Open Access
LIMA1-alpha staining predicts curative intent surgery response in HPV negative head and neck cancer
EMBO Molecular Medicine·2025Open Access
Patient-derived lymphoma organoids and repurposed drugs: novel solutions for improved B cell lymphoma treatment
2025Open Access
408 (PB396): Building insights on the latest novel cancer drugs using pan-cancer ex vivo trials
European Journal of Cancer·2024
1781P Multi-omics of soft tissue sarcomas with complex karyotypes: Investigating genomic and transcriptomic differences between cell lines of the same subtype
Annals of Oncology·2024Open Access
Retraction Notice to: A FBXO7/EYA2-SCFFBXW7 axis promotes AXL-mediated maintenance of mesenchymal and immune evasion phenotypes of cancer cells
Molecular Cell·2024
168P Cardiovascular risks in breast cancer: Insights from BRCA1/2 mutation carriers and sporadic cases
ESMO Open·2024Open Access
In-vitro assays for immuno-oncology drug efficacy assessment and screening for personalized cancer therapy: scopes and challenges
Expert Review of Clinical Immunology·2024· 5 citedOpen Access
Assessment of targeted therapy opportunities in sinonasal cancers using patient-derived functional tumor models
Translational Oncology·2024· 3 citedOpen Access
Ex-vivo drug screening of surgically resected glioma stem cells to replace murine avatars and provide personalise cancer therapy for glioblastoma patients
F1000Research·2024· 1 citedOpen Access
Defined extracellular matrix compositions support stiffness-insensitive cell spreading and adhesion signaling
Proceedings of the National Academy of Sciences·2023· 40 citedOpen Access
2302P Efficacy assessment of targeted and immunotherapies for personalised treatment of melanoma using 2D and 3D ex-vivo assays
Annals of Oncology·2023· 1 citedOpen Access
FBXL12 degrades FANCD2 to regulate replication recovery and promote cancer cell survival under conditions of replication stress
Molecular Cell·2023· 14 citedOpen Access
Ex-vivo drug screening of surgically resected glioma stem cells to replace murine avatars and provide personalise cancer therapy for glioblastoma patients
F1000Research·2023· 11 citedOpen Access
Abstract 1569: OXC-101 kills cancer by disturbing microtubule polymerization and inhibiting MTH1
Cancer Research·2023
Cisplatin overcomes radiotherapy resistance in OCT4-expressing head and neck squamous cell carcinoma
Oral Oncology·2022· 26 citedOpen Access
RETRACTED: A FBXO7/EYA2-SCFFBXW7 axis promotes AXL-mediated maintenance of mesenchymal and immune evasion phenotypes of cancer cells
Molecular Cell·2022· 22 citedOpen Access
Precision oncology using ex vivo technology: a step towards individualised cancer care?
Expert Reviews in Molecular Medicine·2022· 25 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Olli Kallioniemi(15), Rami Mäkelä(9), Johanna Ivaska(8), Ville Härmä(8), Teijo Kuopio(8), Antti Arjonen(7), Olle Sangfelt(7), Juha Kononen(7), Teijo Pellinen(6), Thomas Helleday(5), Matthias Nees(5), Charles Spruck(5), Kristiina Iljin(4), Petra Laasola(4), Joe W. Gray(4), Mari Björkman(4), James A. Wohlschlegel(4), Greg Wells(4), Tuomas Mirtti(3), Dahui Sun(3)